# Evaluation of Triage Options After HPV Testing for Cervical Cancer Screening Among HIV-infected Women

> **NCT03789513** · NA · UNKNOWN · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 3000 (estimated)

## Conditions studied

- HIV Infections
- HPV - Anogenital Human Papilloma Virus Infection

## Interventions

- **DIAGNOSTIC_TEST:** HPV test with partial genotyping and VIA triage

## Key facts

- **NCT ID:** NCT03789513
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-09
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2022-02-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03789513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03789513, "Evaluation of Triage Options After HPV Testing for Cervical Cancer Screening Among HIV-infected Women". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03789513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*